Literature DB >> 7483237

Structure and activity of avermectins and milbemycins in animal health.

W L Shoop1, H Mrozik, M H Fisher.   

Abstract

The avermectins and, to a lesser extent, the milbemycins, have revolutionized antiparasitic and antipest control over the last decade. Both avermectins and milbemycins have macrocyclic lactone structures that are superimposable, they are produced by the same genus of soil dwelling organisms, they have the same mode of action, they exert this action against the same nematode/acarine/insect spectrum of targets, and they show the same mechanism-based toxicity in mammals. Reports suggesting that milbemycins have a different mode of action from avermectins with implications that there will be no mutual resistance to the groups have been shown to be false. Contributing to the belief that there were differences in mode of action between the two groups are the vague definitions of resistance presently in use which rely on the ability of the parasite to survive treatment at the manufacturer's recommended use level. More appropriately, drug resistance should be defined as 'a change in gene frequency of a population, produced by drug selection, which renders the minimal, effective dosage previously used to kill a defined portion (e.g. 95%) of the population no longer equally effective'. This type of definition would allow us to detect changes in susceptibility of a population earlier and is essential when comparing different chemicals to determine if there is mutual resistance to them. It is concluded that much effort has been expended by pharmaceutical, government, and academic scientists searching for broad-spectrum second generation avermectin and milbemycin products, but none has exceeded the original avermectin in any fundamental way. The newer avermectin and milbemycin compounds that have appeared claim niches in the market place based on emphasis of certain narrow parts of the overall spectrum. Consequently, there are no second generation avermectins and milbemycins at present and all newer compounds from this mode of action class are viewed as siblings of the first generation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7483237     DOI: 10.1016/0304-4017(94)00743-v

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  59 in total

1.  Channel-forming properties of the neuropeptide preparation abamectin in bilayer lipid membranes.

Authors:  M G Fomkina; Z Khashaev; V A Drinyaev; L M Chailakhyan
Journal:  Dokl Biochem Biophys       Date:  2001 May-Jun       Impact factor: 0.788

2.  Fate of ivermectin in the terrestrial and aquatic environment: mobility, degradation, and toxicity towards Daphnia similis.

Authors:  Susanne Rath; Leandro Alves Pereira; Sandra Maria Dal Bosco; Milena Guedes Maniero; Anne Hélène Fostier; José Roberto Guimarães
Journal:  Environ Sci Pollut Res Int       Date:  2015-11-18       Impact factor: 4.223

3.  Ivermectin in senegalese peulh sheep: influence of sex on plasma disposition.

Authors:  T Bengone Ndong; Y Kane; E H M Diouf; M Alvinerie
Journal:  Vet Res Commun       Date:  2007-01-27       Impact factor: 2.459

4.  The role of Brugia malayi ATP-binding cassette (ABC) transporters in potentiating drug sensitivity.

Authors:  Jeffrey B Tompkins; Laurel E Stitt; Alana M Morrissette; Bernadette F Ardelli
Journal:  Parasitol Res       Date:  2011-04-15       Impact factor: 2.289

5.  Effectiveness evaluation of several cattle anthelmintics via the fecal egg count reduction test.

Authors:  T A Yazwinski; C A Tucker; J A Hornsby; J G Powell; J L Reynolds; Z B Johnson; W Lindsey; T K Silver
Journal:  Parasitol Res       Date:  2009-02-13       Impact factor: 2.289

6.  Biological and physiological responses of Perionyx excavatus to abamectin.

Authors:  Beewah Ng; Ratmanee Chanabun; Somsak Panha
Journal:  Environ Sci Pollut Res Int       Date:  2019-07-31       Impact factor: 4.223

7.  Comparative evaluation of systemic drugs for their effects against Anopheles gambiae.

Authors:  Matthew P Butters; Kevin C Kobylinski; Kelsey M Deus; Ines Marques da Silva; Meg Gray; Massamba Sylla; Brian D Foy
Journal:  Acta Trop       Date:  2011-10-14       Impact factor: 3.112

8.  Anthelmintics are substrates and activators of nematode P glycoprotein.

Authors:  Dominique Kerboeuf; Fabrice Guégnard
Journal:  Antimicrob Agents Chemother       Date:  2011-02-07       Impact factor: 5.191

9.  Fitness costs associated with low-level dimethoate resistance in Phytoseiulus macropilis.

Authors:  D D M Rezende; M A M Fadini; H G Oliveira; C M Oliveira; J W S Melo; R N C Guedes; A Pallini
Journal:  Exp Appl Acarol       Date:  2013-02-24       Impact factor: 2.132

10.  Moxidectin: a review of chemistry, pharmacokinetics and use in horses.

Authors:  Rami Cobb; Albert Boeckh
Journal:  Parasit Vectors       Date:  2009-09-25       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.